Kairos Pharma, Ltd. (KAPA) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Kairos Pharma, Ltd. (KAPA) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $11.1M, listed on AMEX, employing roughly 1 people, carrying a beta of 1.51 to the broader market. Kairos Pharma, Ltd. Led by John S. Yu, public since 2024-09-16.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for KAPA as of 2026-06-01; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →